ALUMNI

Dr Jason

Weiss

Supported by a Darwin International Scholarship and an Edinburgh Global Overseas Research Scholarship, Jason did his PhD on a pioneering project that resulted in the development of a new class of prodrugs that are activated by palladium catalysis.

 

Publications from his thesis:

  • Nature Communications 2014, 5, 3277.

  • Journal of Medicinal Chemistry 2014, 57, 5395-5404.

  • Frontiers in Chemistry 2014, 2, 56.

  • Scientific Reports 2015, 5, 9329.

Current:

Lead Project Manager at the Biotherapeutic Manufacturing Centre, OHRI (Ottawa, Canada)

Dr Craig

Fraser

Funded by a MRC Doctoral Training Grant, Craig worked on a novel approach to develop small molecule kinase inhibitors with anticancer properties, which led to the discovery of the first in vivo-active SRC/nonABL inhibitor eCF506 and the highly selective mTOR inhibitor eCF309.

Publications from his thesis:

  • MedChemComm 2016, 7, 471-477.

  • Journal of Medicinal Chemistry 2016, 59, 4697–4710.

Current:

Consultant at Lifescience Dynamics Ltd (London, UK)

Dr Sam Myers

Funded by Scottish Power and Cancer Research UK, Sam developed a novel ligand-based phenotypic drug discovery strategy for the development of novel anticancer kinase inhibitors with preferential antiproliferative activity against chemoresistant models of cancer.

Publications from his thesis:

  • Journal of Medicinal Chemistry 2016, 59, 3593–3608.

  • Journal of Medicinal Chemistry 2018, 61, 2104–2110.

Current:

Postdoc, Istituto Italiano di Tecnologia (Genova, Italy)

Dr Thomas Bray

Supported by both the Principal's Career and Development Scholarship and the Edinburgh Global Research Scholarship, Thomas worked on novel palladium-activated bioorthogonal prodrugs. 

 

Publications from his thesis:

  • Chemical Science 2018, 9, 7354-7361.

Current:

Business Manager - China at Oxford Nanopore Technologies Ltd (Oxford, UK)

FORMER POSTDOCS

Dr Belén Rubio-Ruiz

Supported first by a Martín Escudero Foundation Fellowship and then by a Marie Curie Fellowship, Belén worked on novel Pd-activated prodrugs and Pd nanomaterials for anticancer therapy.

Publications from her time in our lab:

  • Journal of Medicinal Chemistry 2016, 59, 9974-9980.

  • ACS Applied Materials & Interfaces 2018, 10, 3341-48.

Current:

Athenea3i Reseach Fellow (H2020-MSCA and UGR cofund) at the Universidad de Granada and GENyO (Granada, Spain)

FORMER STUDENTS AND VISITORS

  • Rafael Contreras (Visiting PhD Student, 2018).  

  • Álvaro Lorente (Visiting PhD Student, 2017). 

  • Hector Yiannakas (Postgrad Summer Student, 2017). 

  • Olga Cruz-Lopez (Visiting Professor, 2017). 

  • Hannah Marlow (Undergrad Student, 2016). 

  • Beatrice Longo (Erasmus Student, 2016). 

  • Inês Lains-Cardoso (Erasmus Student, 2016). 

  • Richard Crispin (PhD Student, 2013-2017). 1st supervisor: Dr E Elizabeth Patton. 2nd supervisor: Dr A Unciti-Broceta.

  • Prabha Peramuhendige (PhD Student, 2011-2015). 1st supervisor: Dr Aymen Idris. 2nd supervisor: Dr A Unciti-Broceta.  

© 2019 by Asier Unciti-Broceta. Proudly created with Wix.com
 

  • Twitter Classic
  • Facebook Classic